{"nct_id":"NCT01232556","title":"A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy","status":"TERMINATED","status_verified_date":"2018-12","start_date":"2011-04-04","start_date_type":"ACTUAL","primary_completion_date":"2014-03-28","primary_completion_date_type":"ACTUAL","completion_date":"2014-03-28","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}